metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Neuroblastic tumors in adults
Información de la revista
Vol. 99. Núm. 2.
Páginas 159-161 (febrero 2021)
Vol. 99. Núm. 2.
Páginas 159-161 (febrero 2021)
Scientific letter
Acceso a texto completo
Neuroblastic tumors in adults
Tumores neuroblásticos en el adulto
Visitas
789
Melody Baeza Murciaa, Graciela Valero Navarrob,
Autor para correspondencia
valerograciela@gmail.com

Corresponding author.
, Benito Flores Pastorb, José Andrés García Marínb, José Luis Aguayo Albasinic
a Médico Interno Residente de Cirugía General y Digestiva del Hospital Universitario Morales Meseguer, Murcia, Spain
b FEA Cirugía General y Digestiva del Hospital Universitario Morales Meseguer, Profesora asociada de la Universidad de Murcia, Murcia, Spain
c Jefe de Servicio de Cirugía General y Digestiva del Hospital Universitario Morales Meseguer, Catedrático de la Universidad de Murcia, Murcia, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (1)
Table 1. Description of worldwide cases of neuroblastic tumors in adults until 20192,3.
Texto completo

Neuroblastic tumors are neoplasms of the sympathetic nervous system originating from primitive sympathetic adrenergic cells formed in the neural crest during embryonic development. They are almost exclusively found in children; their presentation in adults is very rare and associated with a poor prognosis. The location of these tumors is usually intra-abdominal, generally adrenal, and their treatment is surgical whenever possible1. We present the case of a neuroblastic tumor diagnosed in an adult.

A 22-year-old male patient with no relevant personal history underwent an abdominal ultrasound to study mild, nonspecific, self-limited low back pain, as the origin could not be identified as mechanical and/or urinary. As an incidental finding during this ultrasound, a large right retroperitoneal mass was observed. On examination, a mass was palpable that occupied the entire right hemiabdomen, accompanied by mild local discomfort. The patient did not present obstructive intestinal or urological symptoms, fever, or other symptoms. Lab work demonstrated a slight increase in C-reactive protein (CRP) (1.40mg/dL) and a sedimentation rate of 22mm/h; the remaining parameters were normal. After hospital admittance for further study, a computed tomography (CT) scan revealed a voluminous mass occupying the right hypochondrium and flank. The mass measured 15×20×29cm and appeared to have a retroperitoneal origin (the adrenal gland was an initial possibility), with no evidence of lymphadenopathies or metastatic thoracoabdominal extension (Fig. 1). Catecholamine/metanephrine levels in urine were normal.

Fig. 1.

A) A heterogeneous mass measuring 15×20×29cm occupying the right hypochondrium and flank, probably adrenal in origin (identified with an arrow); B) Oval, encapsulated surgical piece measuring 35×20cm that corresponded with the tumor mass described in the imaging tests, originating in the right adrenal gland.

(0.09MB).

At this time, we decided to perform diagnostic-therapeutic surgery. A bilateral subcostal laparotomy revealed a large mass measuring 35×20cm that appeared to originate in the right adrenal gland. It was resected, after identification, ligation and division of the right inferior adrenal artery and vein (Fig. 1b). The histopathological study of the specimen revealed a poorly differentiated intermixed/nodular ganglioneuroblastoma of adrenal origin, with R1 resection margin. Subsequently, the patient was discharged three days after the procedure, with outpatient follow-ups by the Surgery and Oncology Services. On the postoperative 123I-MIBG scintigraphy, there was no evidence of extension at a distance. Treatment with radiotherapy was completed (21Gy [14×1.5Gy]), and the patient was asymptomatic and had no recurrence after 22 months of follow-up.

To assess the frequency of adult neuroblastic tumors, a literature review was performed in PubMed, updated on June 26, 2019, with the following search strategy: ganglioneuroblastoma, and adult. There were 22 cases of adult neuroblastoma found in the current literature2,3, 72% of which were males. The median age of the published cases was 29, ranging from 21 to 67 years (Table 1).

Table 1.

Description of worldwide cases of neuroblastic tumors in adults until 20192,3.

Author  Year  Sex  Age  Size (cm)  Metastasis  Treatment  Survival (S or DFS) 
Butz  1940  Male  25  –  Liver  –  – 
Cameron  1967  Female  58  –  No  Surgery  41 months (S) 
Takahashi  1988  Male  21  8.8  Lymph nodes  Surgery  8 months (S) 
            Radiotherapy   
            Chemotherapy   
Koizumi  1992  Female  47  Bone marrow  –  3 months (S) 
Kishikawa  1992  Male  29  11  Bone  Surgery  – 
Higuchi  1993  Male  29  11  Bone  Surgery  10 months (DFS) 
Hiroshige  1995  Male  35  10  No  Surgery  24 months (S) 
Mehta  1997  Male  22  –  Surgery  – 
Rousseau  1998  Female  –  –  Liver  Surgery  – 
            Radiotherapy   
            Chemotherapy   
Fujiwara  2000  Male  25  –  No  Surgery  60 months (S) 
Leavitt  2000  Male  67  –  No  Surgery  – 
Slapa  2002  Female  20  18  No  Surgery  12 months (DFS) 
Koike  2003  Male  50  4.5  –  Surgery  30 months (S) 
Gunlusoy  2004  Male  59  17  Lymph nodes  Surgery  – 
Mizuno  2006  Male  53  11  Bone  Surgery  30 months (DFS) 
Gupta  2007  Male  40  –  No  Surgery  – 
Bolzacchini  2015  Male  63  No  Surgery  6 months (DFS) 
Qiu  2015  Female  27  11  No  Surgery  5 months (DFS) 
Benedini  2017  Female  21  11  Lymph nodes  Surgery  21 (DFS) 
Lonie  2017  Male  27  17  –  Surgery  – 
Heidari  2017  Male  38  5.5  No  Surgery  3 months (DFS) 
Ramsingh  2018  Female  22  Lymph nodes  Surgery  – 
            Radiotherapy   
            Chemotherapy   
Current case  2019  Male  22  29  No  Surgery  22 months (DFS)
            Radiotherapy 

S: survival; DFS: disease-free survival.

Neuroblastic tumors are classified according to the International Neuroblastoma Pathology Classification (INPC) into four categories based on their morphology, clinical characteristics, and behavior: neuroblastoma, nodular ganglioneuroblastoma, intermixed ganglioneuroblastoma, and ganglioneuroma4. Like paragangliomas and pheochromocytomas, some have the ability to synthesize and secrete catecholamines and cause the symptoms derived from their increase.

These are the most common solid tumors in children under the age of five. Their presentation in adults is very rare, since less than 6% of cases are diagnosed in patients over 20 years of age. Their location is most frequently adrenal, followed in frequency by other intra-abdominal, thoracic, cervical, or pelvic node locations. They generally appear as an abdominal mass with associated abdominal or lumbar pain and/or symptoms derived from metastases, which usually affect lymph nodes, bone, orbits, liver, skin, lung and brain. The diagnosis is made with clinical suspicion and imaging tests such as CT or magnetic resonance imaging (MRI). It is necessary to add a study of catecholamines in urine since these tumors can be functional. Both for the extension and follow-up studies, it is necessary to perform 123I-MIBG scintigraphy. Treatment is surgical, whenever possible. Chemotherapy is used in advanced stages to reduce tumor size, while radiotherapy is used as a complement to surgery when complete resection of the tumor has not been achieved. The prognosis in children is good, and survival increases at lower ages of onset. Adults have a poor prognosis, with 3-year and 5-year survival rates of 46% and 36%, respectively. All the cases in adults that exist in the current literature have a survival of less than 20 years from diagnosis5,6. This case represents a poor prognosis given the age of the patient and his poor differentiation in the anatomopathological characteristics, although the follow-up is still too short to draw prognostic conclusions.

In conclusion, although the onset of neuroblastic tumors in adults is very rare (there are very few cases published in the current literature) and has a poor prognosis, the case we report remains in remission 22 months after surgical and radiotherapy treatment.

References
[1]
K.K. Matthay, J.M. Maris, G. Schleiermacher, A. Nakagawara, C.L. Mackall, L. Diller, et al.
Neuroblastoma.
Nat Rev Dis Primers., 2 (2016), pp. 16078
[2]
E. Bolzacchini, B. Martinelli, G. Pinotti.
Adult onset of ganglioneuroblastoma of the adrenal gland: case report and review of the literature.
Surg Case Rep., 1 (2015), pp. 79
[3]
S. Benedini, G. Grassi, C. Aresta, A. Tufano, L. Carmignani, B. Rubino, et al.
Adrenal ganglioneuroblastoma in adults: a case report and review of the literature.
Case Rep Endocrinol., 2017 (2017), pp. 1-7
[4]
A. Lama.
Update on adrenal tumors in 20017 World Health Organization (WHO) of endocrine tumors.
Endocr Pathol., 28 (2017), pp. 213-227
[5]
W.B. London, R.P. Castleberry, K.K. Matthay, A.T. Look, R.C. Seeger, H. Shimada, et al.
Evidence for an age cutoff greater than 365 days for Neuroblastoma Risk Group stratification in the Children’s Oncology Group.
J Clin Oncol., 23 (2005), pp. 6459-6465
[6]
N. Esiashvili, M. Goodman, K. Ward, R.B. Marcus Jr., P.A. Johnstone.
Neuroblastoma in adults: incidence and a surgical analysis based on SEER data.
Pediatr Blood Cancer., 49 (2007), pp. 41-46

Please cite this article as: Baeza Murcia M, Valero Navarro G, Flores Pastor B, García Marín JA, Aguayo Albasini JL. Tumores neuroblásticos en el adulto. Cir Esp. 2021;99:159–161.

Copyright © 2020. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.cireng.2021.12.008
No mostrar más